Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-001214
Accepted
2022-05-02 00:15:44
Documents
1
Effectiveness Date
2022-04-29
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-22-001214.txt   1939
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-264394 | Film No.: 22879174
SIC: 2836 Biological Products, (No Diagnostic Substances)